SHOULDER INNOVATIONS, INC.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
SI$21.93+2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
(amounts in thousands)
| Three Months Ended | ||
|---|---|---|
| March 31, 2026 | March 31, 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(8,379) | $(4,662) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization | 1,132 | 668 |
| Amortization of debt discounts | 50 | 63 |
| Stock-based compensation expense | 726 | 127 |
| Realized gain on marketable securities | (161) | (162) |
| Other | 120 | — |
| Change in operating assets and liabilities | ||
| Trade accounts receivable | (2,389) | (1,459) |
| Inventory | (238) | 851 |
| Prepaid expenses | (187) | (550) |
| Accounts payable | (3,219) | (2,122) |
| Other current assets and liabilities | 187 | 769 |
| Net cash used in operating activities | (12,358) | (6,477) |
| Cash flows from investing activities | ||
| Fixed asset purchases | (2,735) | (843) |
| Purchases of marketable securities | (18,170) | (20,060) |
| Sales of marketable securities | 17,783 | 7,833 |
| Net cash used in investing activities | (3,122) | (13,070) |
| Cash flows from financing activities | ||
| Proceeds from exercise of common stock options | 101 | 32 |
| Proceeds from exercise of preferred stock warrants | — | 130 |
| Proceeds from Series E convertible preferred stock, net of issuance cost | — | 19,632 |
| Net cash provided by financing activities | 101 | 19,794 |
| Net change in cash for period | (15,379) | 247 |
| Cash and cash equivalents, beginning of period | 26,871 | 6,123 |
| Cash and cash equivalents, end of period | $11,492 | $6,370 |
| Supplemental cash flows information | ||
| Cash paid for interest | $413 | $431 |
| Non-cash investing and financing activities | ||
| Series E convertible preferred stock issuance cost in other current liabilities | $— | $90 |
| Fixed asset purchases included in accounts payable | $1,369 | $263 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.